+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Trizivir"

US HIV Infection Drug Market, Dosage, Price, Sales Insight 2021 - 2026 - Product Thumbnail Image

US HIV Infection Drug Market, Dosage, Price, Sales Insight 2021 - 2026

  • Report
  • February 2021
  • 360 Pages
  • United States
From
  • 1 Results (Page 1 of 1)
Loading Indicator

Trizivir is an antiretroviral medication used to treat HIV infection. It is a combination of three drugs: abacavir, lamivudine, and zidovudine. It is used to reduce the amount of HIV in the body, allowing the immune system to recover and fight off infections. Trizivir is part of a class of drugs known as nucleoside reverse transcriptase inhibitors (NRTIs). NRTIs work by blocking the action of an enzyme called reverse transcriptase, which is needed for HIV to replicate. Trizivir is used in combination with other antiretroviral drugs to treat HIV infection. It is not a cure for HIV, but it can help to reduce the amount of virus in the body and improve the patient's quality of life. It is important to take Trizivir as prescribed and to follow up with regular doctor visits. The Trizivir market is a subset of the larger Infectious Diseases Drugs market. It is a competitive market, with several companies offering Trizivir and other antiretroviral medications. Companies in the Trizivir market include GlaxoSmithKline, Bristol-Myers Squibb, Merck, and Gilead Sciences. Show Less Read more